Darlene Noci sold $321K of Nuvalent (NUVL)

Executed Jul 30 2025, disclosed Aug 1 2025, 2 days later.

Value, as filed

$321K

4,000 sh × $80.36

Executed

Jul 30 2025

the trade date, as filed

Disclosed

Aug 1 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Darlene Noci Chief Development Officer profile →

Darlene Noci (Chief Development Officer) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Nuvalent Inc (NUVL). The largest single filing was $2.8M of NUVL (23,000 sh × $123.59, as filed), executed Jul 1.

The name

NUVL

Nuvalent Inc NUVL · Healthcare · 94 filings in 24 months ticker →

Healthcare · Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Darlene Noci in NUVL

NUVLSALE Nuvalent Inc $2.8M
23,000 sh × $123.59
Exec Jul 1
Filed Jul 6 · 4:31 PM ET NUVLSALE Nuvalent Inc $679K
5,500 sh × $123.51
Exec Jun 29
Filed Jul 1 · 4:30 PM ET NUVLSALE Nuvalent Inc $2.5M
20,000 sh × $122.81
Exec Jun 9
Filed Jun 11 · 5:30 PM ET NUVLSALE Nuvalent Inc $582K
5,400 sh across 4 lots
Exec May 28
Filed Jun 1 · 5:30 PM ET NUVLSALE Nuvalent Inc $447K
4,500 sh × $99.35
Exec Apr 29
Filed May 1 · 5:30 PM ET NUVLSALE Nuvalent Inc $538K
5,500 sh across 2 lots
Exec Mar 30
Filed Apr 1 · 5:30 PM ET NUVLSALE Nuvalent Inc $546K
5,300 sh across 2 lots
Exec Feb 26
Filed Mar 2 · 5:30 PM ET NUVLSALE Nuvalent Inc $536K
5,248 sh across 2 lots
Exec Jan 29
Filed Feb 2 · 5:30 PM ET